Search research articles
Contact Us
Filters
Showing results (1-10 of 182) with videos related to
Page
of 19
Sort By:
Autoimmunity
|
November 16, 2013
Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus
Johanna T Gustafsson, Elisabet Svenungsson
Lupus Science & Medicine
|
May 21, 2020
Could severe COVID-19 be considered a complementopathy?
Katerina Chatzidionysiou, Elisabet Svenungsson, Francesca Faustini
European Journal of Clinical Investigation
|
August 1, 2018
Microparticles as autoantigens in systemic lupus erythematosus
Fariborz Mobarrez, Elisabet Svenungsson, David S Pisetsky
Clinical Kidney Journal
|
August 2, 2016
Ofatumumab treatment in lupus nephritis patients
Malena Loberg Haarhaus, Elisabet Svenungsson, Iva Gunnarsson
Autoimmunity Reviews
|
October 27, 2019
Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies?
Fabiola Atzeni, Elisabet Svenungsson, Michael T Nurmohamed
Rheumatology (Oxford, England)
|
April 3, 2025
Is systemic lupus erythematosus, with or without lupus nephritis, different syndromes, and can genetics contribute to the answer?
Lina-Marcela Diaz-Gallo, Iva Gunnarsson, Elisabet Svenungsson
Lupus Science & Medicine
|
October 27, 2018
Obstetric antiphospholipid syndrome
Aleksandra Antovic, Maria Sennström, Katarina Bremme, et al.
Atherosclerosis
|
November 9, 2004
The A-1087IL-10 allele is associated with cardiovascular disease in SLE
Guo-Zhong Fei, Elisabet Svenungsson, Johan Frostegård, et al.
Arthritis Research & Therapy
|
April 3, 2004
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
Estelle Trysberg, Kina Höglund, Elisabet Svenungsson, et al.
Lupus
|
August 12, 2024
Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness
Arthur Mageau, Julia F Simard, Elisabet Svenungsson, et al.
Page
of 19
Search research articles
Search
Showing results (1-10 of 182) with videos related to
Sort By:
Page
of 19
Autoimmunity
|
November 16, 2013
Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus
Johanna T Gustafsson, Elisabet Svenungsson
Lupus Science & Medicine
|
May 21, 2020
Could severe COVID-19 be considered a complementopathy?
Katerina Chatzidionysiou, Elisabet Svenungsson, Francesca Faustini
European Journal of Clinical Investigation
|
August 1, 2018
Microparticles as autoantigens in systemic lupus erythematosus
Fariborz Mobarrez, Elisabet Svenungsson, David S Pisetsky
Clinical Kidney Journal
|
August 2, 2016
Ofatumumab treatment in lupus nephritis patients
Malena Loberg Haarhaus, Elisabet Svenungsson, Iva Gunnarsson
Autoimmunity Reviews
|
October 27, 2019
Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies?
Fabiola Atzeni, Elisabet Svenungsson, Michael T Nurmohamed
Rheumatology (Oxford, England)
|
April 3, 2025
Is systemic lupus erythematosus, with or without lupus nephritis, different syndromes, and can genetics contribute to the answer?
Lina-Marcela Diaz-Gallo, Iva Gunnarsson, Elisabet Svenungsson
Lupus Science & Medicine
|
October 27, 2018
Obstetric antiphospholipid syndrome
Aleksandra Antovic, Maria Sennström, Katarina Bremme, et al.
Atherosclerosis
|
November 9, 2004
The A-1087IL-10 allele is associated with cardiovascular disease in SLE
Guo-Zhong Fei, Elisabet Svenungsson, Johan Frostegård, et al.
Arthritis Research & Therapy
|
April 3, 2004
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
Estelle Trysberg, Kina Höglund, Elisabet Svenungsson, et al.
Lupus
|
August 12, 2024
Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness
Arthur Mageau, Julia F Simard, Elisabet Svenungsson, et al.
Page
of 19